Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
7
Bullish
3
Bearish
30
Neutral
7
Bullish
9
Bearish
26
Neutral
0
Bullish
6
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Market Cap
₹ 86 Cr
P/E
221.11
Chemicals
Chemicals - Organic - Medium / Small
86 Cr
Moderate Risk
221.1
22.8
—
1.3
51.45
34.20
Sales CAGR
1Y
-11.42%
3Y
-3.07%
5Y
10.37%
10Y
10.28%
Profit CAGR
1Y
-71.10%
3Y
-15.02%
5Y
—
10Y
14.74%
ROE
TTM
1.16%
3Y
10.15%
5Y
11.49%
10Y
7.16%
ROCE
TTM
3.90%
3Y
15.11%
5Y
16.20%
10Y
11.56%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
SLUGGISH
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 2.27 L in last 5 Years
Regulatory Filing
1 day ago
Disclosure of Share Acquisition by Suchit Amin
Suchit Amin disclosed a minor acquisition of 2,865 shares in Archit Organosys Limited, increasing his total holdings to 17,00,256 shares, which represents 8.289% of the total voting rights.
Regulatory Filing
1 day ago
SEBI Disclosure by Suchit Amin
Suchit Amin has disclosed his shareholding in Archit Organosys Limited under Regulation 29(2) of SEBI (SAST) Regulations, detailing acquisition and existing holdings.
Regulatory Filing
4 days ago
Disclosure of Substantial Acquisition
Suchit Kandarp Amin and PACs disclosed their equity acquisition in Archit Organosys Limited under SEBI regulations.